Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure.
Okawa, T., Aramaki, Y., Yamamoto, M., Kobayashi, T., Fukumoto, S., Toyoda, Y., Henta, T., Hata, A., Ikeda, S., Kaneko, M., Hoffman, I.D., Sang, B.C., Zou, H., Kawamoto, T.(2017) J Med Chem 60: 6942-6990
- PubMed: 28699740 
- DOI: 10.1021/acs.jmedchem.7b00443
- Primary Citation of Related Structures:  
5UVC, 5UUU - PubMed Abstract: 
A novel class of therapeutic drug candidates for heart failure, highly potent and selective GRK2 inhibitors, exhibit potentiation of β-adrenergic signaling in vitro studies. Hydrazone derivative 5 and 1,2,4-triazole derivative 24a were identified as ...